The project goal is to draw-up a blueprint document of recommendations for overcoming the innovation hurdles within a selection of targeted business market segments that can make a major contribution to an accelerated take-up of industrial biotechnology (IB) into the market place.This will involve:- Analysis of existing knowledge bank relating to market, research and institutional barriers hindering uptake of IB technology innovations into the market place- Engagement with a broad range of stakeholders across the full multidisciplinary IB spectrum to update, develop and validate these innovation barriers to market entry- Formulation of a roadmap of action plans and policy recommendations for accelerated uptake of IB into a number of targeted product segment areasBio-TIC will compile an in-depth preparation of three “interim roadmaps” comprising market projections, R&D priorities and non-technological barriers to IB market entry. These will act to guide and facilitate a series of convened stakeholder workshops at both national and European level for a full discussion on innovation barriers, in order to validate and further elaborate more comprehensive roadmaps, while taking on board the totality of views from the diverse IB stakeholder base. Finally, the partners will collate and further refine the developed roadmaps into a joint European IB Roadmap and Policy recommendations document, with maximum stakeholder buy-in for wide dissemination and maximum impact.The project will be co-ordinated by EuropaBio- the European Association for Biotechnology Industries, who will also be joined by CEFIC, the European Chemical Industry Council, representing the European chemical industry. These will be joined in the consortium by a further 9 members incorporating innovation agencies, cluster organisations and private management consultancies; all of whom have many complementary skills and expertise and who have worked together in the past on similar initiatives.